We intend to pursue prospective targets in the transportation industry with a focus on companies in North America, Europe and Asia. We expect to acquire one or more growth businesses with a total enterprise value of between $200 million and $600 million. (Incorporated in Delaware) Our search for a target business will include those involved […]

We are a clinical biopharmaceutical drug development company focused on novel therapeutics targeting currently untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration (commonly known as dry AMD) and autosomal recessive Stargardt disease, or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease […]

We intend to focus our search on businesses that are focused on blockchain-related technology, economy, industries and solutions.  We anticipate targeting companies domiciled in North America, Europe and/or Asia that are developing assets in the FinTech, MedTech, Internet of Things, Media, Education, Enterprise and, Blockchain Enabled Verticals, which aligns with our management team’s experience in […]

(Note: Avanea Energy Acquisition Corp. withdrew its SPAC IPO in an SEC filing dated April 20, 2022; the S-1 was filed on March 23, 2021.)  Our focus will be on the energy technology industry in Europe and North America. (Incorporated in the Cayman Islands)  We will search for a target business with an enterprise value […]

(Note: Gateway Strategic Acquisition, a blank check company established by Gaw Capital, withdrew its SPAC IPO in an SEC filing dated April 20, 2022. In July 2021, the SPAC cut its IPO to 20 million units from 30 million units initially. Gateway Strategic Acquisition filed to go public in an S-1 dated March 23, 2021.) […]

We will seek to identify, through our management team’s experience and expertise, a business that aims to power transformation and provide disruptive technological innovation in a range of traditionally managed industries with the ability to leverage innovative intellectual property (“IP”) and data or know-how to develop a sustainable competitive advantage that can dislodge slower moving incumbents in […]

(Note: Biotech Group Acquisition Corp. withdrew its plans for a $75.0 million SPAC IPO in a March 26, 2024, letter to the SEC. The Irvine, California-based SPAC had filed plans to go public on April 15, 2022.) We intend to leverage the knowledge, expertise, capabilities and deep industry relationships of our management team and board of […]

We shall not undertake our initial business combination with any company being based in or having the majority of the company’s operations in China (including Hong Kong and Macau). Our Certificate of Incorporation to be adopted upon the effectiveness of this prospectus prohibit us from undertaking our initial business combination with any company being based […]

We intend to focus our search on companies within the consumer and retail industry. Our affiliation with EF Hutton will allow us to leverage the knowledge and expertise of not only Messrs. Piggott, Rallo and Boral but also of all 54 investment professionals currently employed at the organization. **(Note: EF Hutton is the sole book-running […]

(Note: Laris Media Acquisition Corp. withdrew its SPAC IPO in an SEC filing dated April 19, 2022; the S-1 filed on March 19, 2021.) We intend to focus our search for a target business operating in the audio industry in North America. (Incorporated in the Cayman Islands) We are focused on identifying a business combination target […]